肝细胞特异性对比剂:并非那么简单
本文综述肝细胞特异性对比剂的肝细胞转运与清除机制,并据此讨论儿童及年轻成人肝脏部分肝细胞性病变的影像表现。重点讨论肝胆期呈等或高信号但可能有不良临床结局的病变,并提出识别这些病变的策略。
要点
- 肝胆期病变无对比剂摄取提示无肝细胞或功能差的肿瘤性肝细胞。
- 肝胆期摄取等于或高于背景肝反映有肝细胞存在,但不等于无肿瘤。
- 需理解对比剂摄取与清除机制,以避免儿童及年轻成人肝脏病变误诊。
核心结论
- 肝细胞特异性对比剂在肝胆期的摄取表现需结合摄取与清除机制解读,等或高信号病变仍可能有不良临床结局,准确诊断需理解这些机制以避免误诊。
研究设计与样本
- 综述,讨论肝细胞特异性对比剂的肝细胞转运机制,并据此讨论儿童及年轻成人肝脏部分肝细胞性病变的影像表现及识别策略。
关键影像表现/征象
- 肝胆期病变无对比剂摄取是缺乏肝细胞或肿瘤性肝细胞功能差的标志。
- 肝胆期摄取等于或高于背景肝反映肝细胞存在,但不等于无肿瘤。
- 部分肝细胞性病变在肝胆期呈等或高信号,但可能有不良临床结局。
临床应用与阅片要点
- 解读肝胆期图像需理解对比剂摄取与清除机制,以避免误诊。
- 对肝胆期呈等或高信号的病变需注意识别,因可能有不良临床结局。
- 综述讨论了识别这些病变的策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocyte-specific contrast media are gadolinium chelates that are taken up by hepatocytes and partially cleared via the biliary tree. The absence of lesional uptake of the contrast media in the hepatobiliary phase is a marker of either the absence of hepatocytes or of poorly functioning, neoplastic hepatocytes. Uptake of the contrast media in the hepatobiliary phase, whether equal to or greater than background liver, reflects the presence of hepatocytes but does not equate to absence of neoplasia. Accurate diagnosis of liver lesions utilizing hepatocyte-specific contrast media requires an understanding of the mechanisms of uptake and clearance of the contrast media to avoid misdiagnosis. In this review we discuss the mechanisms of hepatocellular transport of hepatocyte-specific contrast media and utilize an understanding of those mechanisms to discuss the imaging appearance of a subset of hepatocellular lesions that can be seen in the pediatric and young adult liver. We pay particular attention to lesions that appear iso- to hyperintense in the hepatobiliary phase but have the potential for adverse clinical outcomes. We also discuss strategies for identifying these lesions.
引用
- Trout AT, Towbin AJ, Smith EA, et al. Hepatocyte-specific contrast media: not so simple. Pediatr Radiol. 2018. PMID: 30078050. doi:10.1007/s00247-018-4108-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。